https://www.afinalwarning.com/517123.html (Natural News) Doctors in Canada have encountered patients exhibiting symptoms of a mysterious brain condition. The disease shares similarities with Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Medical professionals surmise that environmental toxins are behind the unknown condition.
Roger Ellis is a patient afflicted with the disease. The New Brunswick resident, who is in his early 60s, felt healthy and enjoyed his retirement prior to his diagnosis. Ellis had worked as an industrial mechanic for decades before he retired. But everything changed after he suffered a seizure in June 2019 on his 40th wedding anniversary.
123RF
Those afflicted with the condition - called the New Brunswick Cluster of Neurological Syndrome of Unknown Cause, for now - have ranged in age from 18 to 85 (file photo).
Alier Marrero is stumped. For years, the neurologist in Moncton, New Brunswick, has seen patients with symptoms common to Creutzfeldt-Jakob disease, a fatal brain disorder that affects one in 1 million people each year. But diagnostic testing for the rare neurodegenerative syndrome keeps coming back negative, more patients with similar symptoms have turned up each year, and Marrero hasn t found another cause. Federal public health officials last year identified the cases as a cluster meriting further investigation.
increase font size
Mysterious, devastating brain disorder afflicts dozens in New Brunswick
Across the border in Maine, officials say their disease surveillance and epidemiology teams learned about the cluster in March, but no cases have been reported there.
By Amanda ColettaThe Washington Post
Alier Marrero is stumped.
For years, the neurologist in Moncton, New Brunswick, has seen patients with symptoms common to Creutzfeldt-Jakob disease, a fatal brain disorder that affects one in 1 million people each year.
But diagnostic testing for the rare neurodegenerative syndrome keeps coming back negative, more patients with similar symptoms have turned up each year, and Marrero hasn’t found another cause. Federal public health officials last year identified the cases as a cluster meriting further investigation.
A mysterious, devastating brain disorder is afflicting dozens in one Canadian province Amanda Coletta Alier Marrero is stumped. For years, the neurologist in Moncton, New Brunswick, has seen patients with symptoms common to Creutzfeldt-Jakob disease, a fatal brain disorder that affects 1 in 1 million people each year. But diagnostic testing for the rare neurodegenerative syndrome keeps coming back negative, more patients with similar symptoms have turned up each year, and Marrero hasn’t found another cause. Federal public health officials last year identified the cases as a cluster meriting further investigation. Now Marrero and scientists and doctors from Canada and around the world are playing detective in a medical whodunit, racing to untangle the cause of the brain disorder that has afflicted 48 people, six of whom have died, in the Moncton area and New Brunswick’s Acadian peninsula.
(0)
TORONTO and CAMBRIDGE, Mass., May 12, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company s scientific advisory board (SAB). Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital.